Source Job

$325,000–$376,000/yr

  • Lead Braveheart’s global PV strategy and partner closely with Clinical, Regulatory, and other development functions.
  • Lead all PV contributions to Investigational New Drug (IND) and Clinical Trial Application (CTA) submissions worldwide, with responsibility for developing high-quality safety sections.
  • Shape the future PV function— its people, structure, and operating model— as Braveheart transitions from clinical development to post-market commercialization.

Communication

3 jobs similar to Senior Director, Pharmacovigilance

Jobs ranked by similarity.

US 5w PTO

  • Lead global pharmacovigilance operations and ensure the safety of clinical and post-marketing products.
  • Collaborate with cross-functional teams to maintain compliance with global regulatory standards.
  • Drive continuous improvement of PV systems and processes while contributing to medical safety strategy.

This position is posted by Jobgether on behalf of a partner company; Jobgether uses an AI-powered matching process to ensure your application is reviewed quickly.

US

  • Support operational planning, start-up, execution, and close-out activities for Phase 3 clinical studies in HCM.
  • Oversee CROs, vendors, clinical sites, and external partners to ensure delivery of high-quality data, adherence to timelines, and compliance with GCP and regulatory requirements.
  • Lead selection, onboarding, and oversight of CROs, central labs, imaging vendors, and specialty service providers.

Braveheart Bio is a Bay Area–based biopharmaceutical company pioneering best-in-class therapies for cardiovascular disease.

Unlimited PTO

  • Provide clinical scientific leadership for the clinical development organization.
  • Lead the design and writing of clinical protocols and associated clinical documents.
  • Represent Immunovant externally and build successful relationships with multiple stakeholders including trial site Investigators, KOLs, and others.

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases.